CSF3 and neoplasm: Together, these results suggest tumors can shift the net balance of immune-stimulatory and immune-suppressive BM and peripheral myeloid cells via alteration of IRF8 expression through regulation of inflammatory cytokines like GCSF, thereby blunting anti-tumor immunity.